Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Conditions:   Hepatocellular Carcinoma;   Liver Transplantation Intervention:   Drug: relenvatinib group Sponsor:   RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials